|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/12 | (2006.01) |
| A61K 39/40 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Patento numeris | 2305295 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10010739.0 |
| Europos patento paraiškos padavimo data | 2005-09-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-04-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-04-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0421082 | 2004-09-22 | GB | |
| 0421078 | 2004-09-22 | GB | |
| 0421081 | 2004-09-22 | GB | |
| 0421079 | 2004-09-22 | GB | |
| 0503143 | 2005-02-15 | GB |
| (72) |
Castado, Cindy, BE
Lecrenier, Nicolas Pierre Fernand, BE
Neyt, Ceclie Anne, BE
Poolman, Jan, BE
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | Antibody composition for use in vaccination against staphylococcei |
| Antibody composition for use in vaccination against staphylococcei |